Cite
HARVARD Citation
Ren, X. et al. (2018). Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus. Bioscience reports. 38 (6), p. . [Online].